<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0"
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main" xml:id="_gHr35AR">Effects of aerobic training and resistance training in reducing cardiovascular disease risk for patients with prediabetes: A multi-center randomized controlled trial</title>
				<funder ref="#_pMCevZk">
					<orgName type="full">Natural Science Foundation of China</orgName>
				</funder>
				<funder>
					<orgName type="full">Affiliated Hospital of Integrated Traditional Chinese and Western Medicine</orgName>
				</funder>
				<funder ref="#_376A4fy">
					<orgName type="full">Research Project of State Administration of Traditional Chinese Medicine</orgName>
				</funder>
				<funder>
					<orgName type="full">Nanjing University of Chinese Medicine</orgName>
					<orgName type="abbreviated">NJUCM</orgName>
					<idno type="DOI" subtype="crossref">https://doi.org/10.13039/501100007956</idno>
				</funder>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability  status="unknown">
					<licence/>
					<p type="raw">© 2021 Published by Elsevier Ltd on behalf of Primary Care Diabetes Europe. © 2021 Published by Elsevier Ltd on behalf of Primary Care Diabetes Europe.</p>
				</availability>
				<date type="published" when="2021-10-11">11 October 2021</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Xue</forename><surname>Chen</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>a</label> Hainan General Hospital , Haikou , Hainan , China</note>
								<orgName type="institution">Hainan General Hospital</orgName>
								<address>
									<settlement>Haikou Hainan</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>b</label> Jiangsu College of Nursing , Huai&apos;an , Jiangsu , China</note>
								<orgName type="institution">Jiangsu College of Nursing</orgName>
								<address>
									<settlement>Huai&apos;an Jiangsu</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Songqing</forename><surname>Zhao</surname></persName>
							<affiliation key="aff2">
								<note type="raw_affiliation"><label>c</label> Huai&apos;an Hospital Affiliated to Nanjing Medical University , China</note>
								<orgName type="department">Huai&apos;an Hospital Affiliated to</orgName>
								<orgName type="institution">Nanjing Medical University</orgName>
								<address>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Cunyi</forename><surname>Hsue</surname></persName>
							<affiliation key="aff3">
								<note type="raw_affiliation"><label>d</label> University of Massachusetts Amherst , USA</note>
								<orgName type="institution">University of Massachusetts</orgName>
								<address>
									<settlement>Amherst</settlement>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Xia</forename><surname>Dai</surname></persName>
							<affiliation key="aff4">
								<note type="raw_affiliation"><label>e</label> The First Affiliated Hospital of Guangxi Medical University , China</note>
								<orgName type="department">The First Affiliated Hospital</orgName>
								<orgName type="institution">Guangxi Medical University</orgName>
								<address>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Lin</forename><surname>Liu</surname></persName>
							<affiliation key="aff5">
								<note type="raw_affiliation"><label>f</label> Yangzhou University , China</note>
								<orgName type="institution">Yangzhou University</orgName>
								<address>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Joshua</forename><forename type="middle">D</forename><surname>Miller</surname></persName>
							<affiliation key="aff6">
								<note type="raw_affiliation"><label>g</label> Stony Brook University Hospital , NY , USA</note>
								<orgName type="institution">Stony Brook University Hospital</orgName>
								<address>
									<region>NY</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Zhaohui</forename><surname>Fang</surname></persName>
							<affiliation key="aff7">
								<note type="raw_affiliation"><label>h</label> The First Affiliated Hospital of Anhui University of Chinese Medicine , China</note>
								<orgName type="department">The First Affiliated Hospital</orgName>
								<orgName type="institution">Anhui University of Chinese Medicine</orgName>
								<address>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jitao</forename><surname>Feng</surname></persName>
							<affiliation key="aff8">
								<note type="raw_affiliation"><label>i</label> Affiliated Hospital of Integrated Traditional Chinese and Western Medicine , Nanjing University of Chinese Medicine , Nanjing , Jiangsu , China</note>
								<orgName type="department">Affiliated Hospital of Integrated Traditional Chinese and Western Medicine</orgName>
								<orgName type="institution">Nanjing University of Chinese Medicine</orgName>
								<address>
									<settlement>Nanjing Jiangsu</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Yong</forename><surname>Huang</surname></persName>
							<affiliation key="aff9">
								<note type="raw_affiliation"><label>j</label> Danyang People&apos;s Hospital of Jiangsu Province , China</note>
								<orgName type="department">Danyang People&apos;s</orgName>
								<orgName type="institution">Hospital of Jiangsu Province</orgName>
								<address>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Xindong</forename><surname>Wang</surname></persName>
							<affiliation key="aff8">
								<note type="raw_affiliation"><label>i</label> Affiliated Hospital of Integrated Traditional Chinese and Western Medicine , Nanjing University of Chinese Medicine , Nanjing , Jiangsu , China</note>
								<orgName type="department">Affiliated Hospital of Integrated Traditional Chinese and Western Medicine</orgName>
								<orgName type="institution">Nanjing University of Chinese Medicine</orgName>
								<address>
									<settlement>Nanjing Jiangsu</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Qingqing</forename><surname>Lou</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>a</label> Hainan General Hospital , Haikou , Hainan , China</note>
								<orgName type="institution">Hainan General Hospital</orgName>
								<address>
									<settlement>Haikou Hainan</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff10">
								<note type="raw_affiliation">Hainan General Hospital , No.19 , Xiuhua Road , Xiuying District , Haikou 570311 , Hainan , China.</note>
								<orgName type="institution">Hainan General Hospital</orgName>
								<address>
									<addrLine>No.19 Xiuhua Road Xiuying District</addrLine>
									<postCode>570311</postCode>
									<settlement>Haikou Hainan</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main" xml:id="_3pVnkmc">Effects of aerobic training and resistance training in reducing cardiovascular disease risk for patients with prediabetes: A multi-center randomized controlled trial</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2021-10-11">11 October 2021</date>
						</imprint>
					</monogr>
					<idno type="MD5">539838CCFFF224BCE29A8F51CB16FD08</idno>
					<idno type="DOI">10.1016/j.pcd.2021.08.013</idno>
					<note type="submission">Received 4 September 2020 Received in revised form 17 August 2021 Accepted 24 August 2021</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-08-31T05:20+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">a91ee48</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=2, consolidateHeader=2, consolidateFunders=1, includeRawAffiliations=true, includeRawCitations=true, includeRawCopyrights=true, generateTeiIds=true, generateTeiCoordinates=[all], sentenceSegmentation=true, flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords xml:id="_Hkfq67F">Prediabetes Aerobic training Resistance training Cardiovascular disease risk NCT 02561377</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0" xml:id="_MrpasdX"><p xml:id="_9tvYcnz"><s xml:id="_yZTbfHj">Aims: Aerobic training (AT) and resistance training (RT) can reduce blood glucose and type 2 diabetes risk, and increase muscle mass for prediabetes patients.</s><s xml:id="_ENexthh">However, the impact of long-term AT and RT on cardiovascular disease (CVD) risk remains unclear.</s><s xml:id="_ky4MnUx">The purpose of this study was to investigate the impact of AT and RT on CVD risk reduction in prediabetes patients.</s><s xml:id="_fHVq7wB">Materials and methods: 248 prediabetes patients were enrolled in this multi-center randomized controlled trial (RCT).</s><s xml:id="_B2WsQ6c">Patients were randomly divided into 3 groups: RT (n = 82), aerobic training (AT (n = 83)), and control group (n = 83).</s><s xml:id="_K77Mh8B">Participants in RT and AT groups had moderate RT or AT 3 times a week (150 min/week) under supervision in 3 research centers for 24 months.</s><s xml:id="_UjzCDPK">Primary outcome was CVD risk measured by Framingham Risk Score (FRS) and The Chinese 10-year ischemic cardiovascular disease (ICVD) risk assessment tool.</s><s xml:id="_PmGEDPp">Secondary outcomes included in HOMA2-IR, HbA1c, blood pressure and serum lipid profile.</s><s xml:id="_hxHjMM4">Results: Both RT and AT groups experienced a significant reduction in HOMA2-IR, HbA1c, LDL-C, TC, SBP, and DBP at the end of 12 and 24 months.</s><s xml:id="_vnmUsUy">Compared to the control group, Both RT and AT groups had significant reduction of the Chinese 10-year ICVD risk (P &lt; 0.05), but FRS CVD risk declined significantly only in the AT group (all P &lt; 0.05).</s><s xml:id="_VkjvQab">Although FRS CVD risk decreased more in the RT group than in the control group, the difference was not statistically significant.</s><s xml:id="_eJYJqNJ">After adjusting for age, gender, statin use, BMI, and WHR, in COX's proportional hazard model, RT (HR = 0.419, P = 0.037) and AT (HR = 0.310, P = 0.026) were protective factors for CVD risk in prediabetes patients.</s><s xml:id="_ZkyYFfu">24-month RT and AT decreased respectively 58.1% and 69.0% of CVD risk (10-year ICVD risk assessment) in prediabetes patients.</s><s xml:id="_kKkUtkg">Conclusions: This study demonstrated that 24-month moderate AT reduces the Chinese 10-year ICVD risk and FRS CVD risk in prediabetes patients.</s><s xml:id="_FgsyhQs">RT groups had significant reduction of CVD risk (10-year ICVD risk assessment) in prediabetes patients.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<facsimile>
		<surface n="1" ulx="0.0" uly="0.0" lrx="595.28" lry="793.7"/>
		<surface n="2" ulx="0.0" uly="0.0" lrx="595.28" lry="793.7"/>
		<surface n="3" ulx="0.0" uly="0.0" lrx="595.28" lry="793.7"/>
		<surface n="4" ulx="0.0" uly="0.0" lrx="595.28" lry="793.7"/>
		<surface n="5" ulx="0.0" uly="0.0" lrx="595.28" lry="793.7"/>
		<surface n="6" ulx="0.0" uly="0.0" lrx="595.28" lry="793.7"/>
		<surface n="7" ulx="0.0" uly="0.0" lrx="595.28" lry="793.7"/>
		<surface n="8" ulx="0.0" uly="0.0" lrx="595.28" lry="793.7"/>
	</facsimile>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1." xml:id="_E8k2MZg">Introduction</head><p xml:id="_nctR6Ez"><s xml:id="_R3sa66N">Prediabetes, also known as impaired glucose regulation (IGR), includes both impaired glucose tolerance (IGT) and/or impaired fasting glucose (IFG).</s><s xml:id="_Pe5mtc6">It was important to notice that prediabetes have significant insulin resistance which can initiate the process of cardiovascular disease (CVD) <ref type="bibr" target="#b0">[1]</ref>.</s><s xml:id="_WSbNU7r">A British study <ref type="bibr" target="#b1">[2]</ref> followed up the population without baseline CVD or known diabetes (n = 357,833) for 8.9 years and found that compared with the reference group, prediabetes was at higher CVD risk: hazard ratio (HR) 1.83.</s><s xml:id="_FhFQXua">A meta-analysis <ref type="bibr" target="#b2">[3]</ref> showed that prediabetes (IGT or IFG according to IFG-ADA or IFG-WHO criteria) was associated with an increased risk of CVD (relative risk 1.13, 1.26, and 1.30 for IFG-ADA, IFG-WHO, and IGT, respectively).</s></p><p xml:id="_xcAdZZz"><s xml:id="_SaryUZK">Exercise is an effective way to reduce the risk of CVD.</s><s xml:id="_SXMFq68">Exercise paradigms to prevent CVD have historically been focused on aerobic activity.</s><s xml:id="_pDJaXxZ">Our team reported that supervised resistance training (RT) reduced insulin resistance, HbA1c, SBP, LDL-C <ref type="bibr" target="#b3">[4]</ref> and abdominal adipose, and augmented muscle mass <ref type="bibr" target="#b4">[5]</ref>.</s><s xml:id="_g87WwtS">Two flow-up studies from the US reported that a risk reduction of 17% for CVD was observed among healthy men and women engaging in RT with a follow-up period of 18 and 14 years <ref type="bibr" target="#b5">[6,</ref><ref type="bibr" target="#b6">7]</ref>.</s><s xml:id="_T8UBPFb">However, whether long-term RT can reduce the risk of CVD in patients with prediabetes is unclear.</s></p><p xml:id="_spswAYN"><s xml:id="_n3SptVG">Therefore, the purpose of this multi-center RCT was to investigate the impact of 24-month resistance training on the reduction of cardiovascular disease risk on patients with prediabetes.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2." xml:id="_kwVxwF3">Materials and methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.1." xml:id="_aD5xzNe">Participants</head><p xml:id="_RxQT4Sr"><s xml:id="_3rY3dNh">Participants were enrolled through three centers (The Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine.</s><s xml:id="_GfxnQMg">Dan yang People's Hospital of Jiangsu Province, The First Affiliated Hospital of Guangxi Medical University) from January to December 2014.</s><s xml:id="_ngHPC75">Eligibility criteria included: age more than 50 years, less than 75 years and a diagnosis of prediabetes based on <ref type="bibr" target="#b0">(1)</ref> fasting blood glucose between 100 mg/dL (5.6 mmol/L) and 126 mg/dL (7.0 mmol/L) (IFG) on two separate occasions, or (2) positive oral glucose tolerance test (OGTT) -a blood glucose concentration between 140 mg/dL (7.8 mmol/L) and 200 mg/dL (11.1 mmol/L) two hours following ingestion of 75 g oral glucose (IGT), or (3) hemoglobin A1c (HbA1c) between 5.7% and 6.4% <ref type="bibr" target="#b7">[8]</ref> on two separate occasions.</s><s xml:id="_RmJxjGS">Patients without known previous diagnosis of prediabetes as well as those with a pre-existing history of prediabetes were enrolled following a confirmatory Oral glucose tolerance test (OGTT) at baseline.</s><s xml:id="_rm3bCqq">Participants were excluded if they were previously diagnosed with diabetes, cardiovascular diseases, or cerebrovascular diseases, were pregnant or breastfeeding, had severe physical disability, or did not have the intellectual or emotional capability to follow the study protocol.</s><s xml:id="_v6RtYbM">All female participants were pre-menopausal.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.2." xml:id="_ZH4u5vm">Trial design and randomization</head><p xml:id="_SAMsKwz"><s xml:id="_bA2qmEZ">A total of 248 participants met the criteria and were enrolled in the study (Fig. <ref type="figure" target="#fig_1">1</ref>).</s><s xml:id="_B378CTJ">Participants were assigned to one of three groups using numbers generated randomly by computer: (1) a control group (C group, n = 83); ( <ref type="formula">2</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.3." xml:id="_yTqeNMB">Intervention</head><p xml:id="_sBBcpFk"><s xml:id="_KpSUYgd">For safety purposes, all participants were assessed maximal oxygen consumption (VO 2 max) at baseline.</s><s xml:id="_mSRBx52">The control group was instructed to maintain their usual habits and received no structured exercise intervention or counseling.</s><s xml:id="_fBfNrH5">The intervention groups were supervised by study personnel, all of whom received professional training about each intervention paradigm.</s><s xml:id="_J32HA6M">Patients in AT group performed aerobic dance at 60-70% of maximum heart rate.</s><s xml:id="_jEgEu2C">AT sessions lasted 60 min each, 3 times per week (including 5 min of warm-up, 50 min of aerobic dancing and 5 min of stretching exercises).</s><s xml:id="_4wM8tYp">RT by way of elastic bands ($2, Huoshuai, China) occurred 3 times per week at 50 min per session.</s><s xml:id="_mYQu36r">There were 13 exercise pieces in the protocol: leg presses, leg extensions, chest presses, pull downs, rowing motions, calf raise, seated leg curl, shoulder presses, straight-arm forwards, straight-arm backwards, leg rotation left, leg rotation right and abdominal crunch movements.</s><s xml:id="_t4YHtbd">The details about screening VO 2 max, aerobic and resistance training programs have been previously reported <ref type="bibr" target="#b3">[4]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.4." xml:id="_RWpd2a4">Evaluation</head><p xml:id="_6XRPS8M"><s xml:id="_ejpjKKx">Assessments were conducted on day 1 (baseline) and at the end of months 12 and 24 respectively.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.4.1." xml:id="_FZtzHtp">Oral glucose tolerance test (OGTT)</head><p xml:id="_hFUqvu5"><s xml:id="_sF4nqAe">All subjects underwent baseline, 12 and 24-month OGTT.</s><s xml:id="_j3aZ4Xb">The following is a brief description of OGTT procedure.</s><s xml:id="_aXM6yQ2">Blood samples were taken after an overnight (10-h) fasting and 2-h after 75 g glucose intake respectively, for OGTT measurements.</s></p><p xml:id="_WTfHwHJ"><s xml:id="_B4KgeBw">Plasma glucose was analyzed by a YSI 2700 Select Biochemistry Analyzer (YSI, Inc., Yellow Springs, OH).</s><s xml:id="_4BewYmQ">Serum insulin was measured by solid-phase, enzyme-labelled chemiluminescent immunometric assay (Immulite 2000; Diagnostic Products, Los Angeles, CA).</s><s xml:id="_EVrxesv">HbA1c was determined by high performance liquid chromatography (Bio-Rad Diamat, Munich, Germany).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.4.2." xml:id="_J7MH2Ux">Cardiovascular disease risk</head><p xml:id="_ecg6BEE"><s xml:id="_cwsycMH">Cardiovascular disease (CVD) risk was assessed using Framingham Risk Score (FRS) <ref type="bibr" target="#b8">[9]</ref> and The Chinese 10-year ischemic cardiovascular disease (ICVD) risk assessment tool <ref type="bibr" target="#b9">[10]</ref>.</s></p><p xml:id="_N5PYm9H"><s xml:id="_gk2N5p2">FRS was used to calculate the risk of CVD in 10 years, in which gender, age, TC, HDL-C, SBP and smoking status were considered as risk factors.</s><s xml:id="_z5e44Uj">After the total score was calculated, the 10-year risk can be rated accordingly.</s></p><p xml:id="_KTD2dS5"><s xml:id="_p64WKFE">A Chinese task group of the national Fifteen Project developed sex-specific optimal 10-year risk prediction models in the China MUCA study cohort II.</s><s xml:id="_2WR8AbX">Distinct from models developed in the western countries, the Chinese 10-year ICVD risk model estimates total ICVD risk (both coronary heart disease and stroke).</s><s xml:id="_BqWDxmZ">It is appropriate for Chinese racial and ethnic groups and has been incorporated into current Chinese guidelines for cardiovascular disease prevention.</s><s xml:id="_aXVbKMu">FRS did not include diabetes or hyperglycemia, which is an important risk factor for CVD, the Chinese 10-year ICVD risk assessment is suitable for the Chinese population, which included gender, age, SBP, BMI, TC, smoking statuses and having/not having diabetes as risk factors.</s><s xml:id="_vq8MmXC">After the total score was calculated, the 10-year risk can be rated accordingly.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.4.3." xml:id="_9zWwdmT">Blood lipid assays and anthropometric measures</head><p xml:id="_AHnWGz6"><s xml:id="_6zuVreA">The fasting serum concentrations of total cholesterol, highdensity lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol and plasma triacylglycerol were determined by colorimetric methods using commercial kits (Abbott, Abbott Park, IL) with an Architect c8000 analyzer (Abbott) according to the instructions of the Manufacturer.</s><s xml:id="_PHK6Ar9">Body weight and height were measured in all participants wearing light clothing and standing barefoot.</s><s xml:id="_KbC9cgg">Body mass index (BMI) was calculated from weight and height (kg/m 2 ).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.4.4." xml:id="_Tdst98M">Calculation of HOMA2-IR and HOMA2-Ť</head><p xml:id="_pVcC6s4"><s xml:id="_ac2VhBa">he ␤ cell function index (HOMA2-␤) and insulin resistance index (HOMA2-IR) of this study were calculated by HOMA2 calculation software (<ref type="url" target="https://www.dtu.ox.ac.uk/homacalculator/">https://www.dtu.ox.ac.uk/homacalculator/</ref> download) <ref type="bibr" target="#b10">[11]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.5." xml:id="_DCsNrXm">Statistical analyses</head><p xml:id="_SwWyFsM"><s xml:id="_55saZvP">Power and sample size calculations were reported previously <ref type="bibr" target="#b3">[4]</ref>.</s><s xml:id="_XUKfRh7">Statistical analysis was performed using SPSS 22.0 software.</s><s xml:id="_HsmnEAC">The normality of distribution was assessed by skewness and kurtosis analysis.</s><s xml:id="_yHR9Zur">Baseline data were compared by one-way analysis of variance (ANOVA) or Kruskal-Wallis analysis.</s><s xml:id="_3m8tasD">Logarithmic transformation (log10) and Square root transformation was performed if the data was not normally distributed.</s><s xml:id="_ydRbUDY">Longitudinal changes between groups were tested with repeated-measure analysis of variance.</s><s xml:id="_49suquF">The hazard ratios for CVD were calculated by Cox's proportional hazard model adjusted for age, sex, statin use, BMI, and WHR.</s><s xml:id="_45dQqMK">Statistical significance was defined as P &lt; 0.05.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3." xml:id="_qSagVnB">Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.1." xml:id="_xdv6Epf">Patient population</head><p xml:id="_ASUA9qK"><s xml:id="_B2CY4ue">A total of 248 patients were included, and 173 patients (69.7%) completed the 24-month study.</s><s xml:id="_tNHCGVY">During the 24-month study, two cases of hypoglycemic events were reported assume this means during the study.</s><s xml:id="_yEaTBnY">Immediate remedial action was taken to make sure that no one was injured.</s><s xml:id="_RjApWB2">No other exercise-related adverse events were found.</s><s xml:id="_dfhJD3X">Rate of drop out in the AT, RT and control groups were 25, 22, and 28 respectively, due most commonly to personal reasons or scheduling conflict.</s><s xml:id="_pG8PVMa">17 participants were lost to follow up.</s><s xml:id="_NvcrhBF">All participants were included in the intention-to-treat analyses.</s><s xml:id="_x7cPjsK">As shown in Table <ref type="table" target="#tab_0">1</ref>, there were no differences in baseline variables across groups.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.2." xml:id="_cDZEchp">Between-group differences in HOMA2-IR, HOMA2-ˇ, FPG, 2hPG and HbA1c</head><p xml:id="_Sq56FX7"><s xml:id="_eDBpDkP">As shown in Table <ref type="table" target="#tab_1">2</ref>, there were several statistically significant differences in HOMA2-IR, HOMA2-␤, FPG, 2hPG, and HbA1c among three groups and between AT and RT groups.</s><s xml:id="_Jc5rBDb">After 24-month training, HOMA2-IR, FPG, 2hPG and HbA1c increased significantly in the control group and declined in the AT and RT groups; while HOMA2-␤ decreased significantly in the control group and increased in the AT and RT groups (all P &lt; 0.01).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.3." xml:id="_tcb3cdJ">Between-group differences in CVD risk</head><p xml:id="_zwmgsyF"><s xml:id="_xw8tJYj">As shown in Table <ref type="table" target="#tab_2">3</ref>, at the end of 12-month training, compared to the control group, both RT and AT groups had significant reduc-  tion of the Chinese 10-year ICVD risk (P &lt; 0.05), but FRS CVD risk declined significantly only in the AT group (all P &lt; 0.05).</s><s xml:id="_dvdNFmy">Although FRS CVD risk decreased more in the RT group than in the control group, the difference was not statistically significant.</s><s xml:id="_fZdefSx">After adjusting for age, gender, statin use, BMI, and WHR, in COX's proportional hazard model, resistance (HR = 0.419, P = 0.037) and aerobic exercise (HR = 0.310, P = 0.026) were protective factors for CVD risk in prediabetes patients.</s><s xml:id="_CyssZF2">24-month resistance and aerobic training decreased respectively 58.1% and 69.0% of CVD risk (10-year ICVD risk assessment) in prediabetes patients (Table <ref type="table" target="#tab_3">4</ref>, Fig. <ref type="figure" target="#fig_4">4</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.4." xml:id="_T7CHAap">Between-group differences in TG, TC, DBP, HDL, LDL and SBP</head><p xml:id="_ZRCQHDE"><s xml:id="_ZXCafSe">After 24-month training, TC, LDL, DBP and SBP improved in both AT and RT groups compared to those in the control group (all P &lt; 0.05).</s><s xml:id="_sq6qNUU">However, no significant difference was found between experimental groups and controls group for TG and HDL (Table <ref type="table" target="#tab_1">2</ref>).</s><s xml:id="_RSsyA5j">Fig. <ref type="figure" target="#fig_3">3</ref> depicts results for Framingham Risks (%) and ICVD Risks (%) before and after 12-and 24-month training.</s><s xml:id="_aUthpSq">There was a significant difference in the decrease of Framingham Risks (%) and ICVD Risks (%) in exercise groups in within-group analyses (All P &lt; 0.05).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.5." xml:id="_qRpkUUz">Within-group comparison in HbA1c and CVD risk</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.6." xml:id="_xAYmnXN">The incidence of diabetes in the 3 groups after 24-month training</head><p xml:id="_GbJVADC"><s xml:id="_NtwPQ5n">In our study, we found 14 patients in the RT, 15 in the AT, and 30 in the control group had developed diabetes, with a cumulative 24-month incidence of 17.1%, 18.1%, and 36.1%,</s><s xml:id="_9JYk4Tb">respectively.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4." xml:id="_sj875pr">Discussion</head><p xml:id="_HfJHmez"><s xml:id="_6gRaADV">This multi-center randomized controlled trail with relatively large sample size and long duration demonstrated that RT reduced the risk of CVD in participants with prediabetes.</s><s xml:id="_ShvqJEK">This association was not explained by other known CVD risk factors, including BMI.</s></p><p xml:id="_4XMEgUd"><s xml:id="_7Q9Jjue">Our study found that AT but not RT reduced the risk of CVD based on FRS.</s><s xml:id="_ggZCpYH">It should be noted that diabetes status, a known coronary risk equivalent, was not taken into account in the Framingham Score rubric <ref type="bibr" target="#b11">[12]</ref>.</s><s xml:id="_RwpZXJ6">Thus, the Chinese 10-year ICVD risk assessment tool was developed to include diabetes in determining CVD risk <ref type="bibr" target="#b12">[13]</ref>.</s><s xml:id="_cUMCscV">By using it, we found that RT reduced CVD risk by 58.1%.</s><s xml:id="_bVhHUw6">This was similar to the results of the follow-up study in the U.S. through 14 years of follow-up, this study found that RT reduced the risk of CVD in healthy women by 17% <ref type="bibr" target="#b6">[7]</ref>.</s><s xml:id="_QpsJypF">Another 18-year follow-up study of male health professionals found that RT reduced CVD risk by 17% <ref type="bibr" target="#b5">[6]</ref>.</s><s xml:id="_W8Qts94">The magnitude of reduction in these two studies were smaller than that of our study.</s><s xml:id="_twztfpW">Three factors might account for this difference.</s><s xml:id="_zx8AaTr">First, Participants in our study were prediabetes with higher risk of CVD.</s><s xml:id="_FzTSPM2">Participants in these two studies were healthy men and women.</s><s xml:id="_69gR7kY">Second, in our study, participants attended one of three centers to complete their study routines and the exercises were supervised by study personnel.</s><s xml:id="_47BjRmk">In these two studies, exercises were recorded by self-report.</s><s xml:id="_gFwWP6h">Third, in our study, we used the FRS and the Chinese 10-year ICVD risk assessment tool to measure the CVD risk.</s><s xml:id="_qv5FyUZ">In these two studies, Cases of cardiovascular disease were defined as confirmed cases of myocardial infarction, stroke, coronary artery bypass graft, angioplasty, or cardiovascular disease death <ref type="bibr" target="#b6">[7]</ref>.</s><s xml:id="_C2tnyWd">Study physicians reviewed medical records to confirm cases of cardiovascular disease.</s></p><p xml:id="_PnyVs2Y"><s xml:id="_EFavMKc">Previous studies examining biomarkers and risk factors may provide a mechanistic explanation of the independent benefit of RT.</s><s xml:id="_Utxf2Fu">To begin with, our previous studies showed that RT reduced visceral fat and increased muscle mass <ref type="bibr" target="#b4">[5]</ref>, therefore decreased insulin resistance <ref type="bibr" target="#b3">[4]</ref>.</s><s xml:id="_FYcrJBz">Moreover, RT reduced inflammatory factors such as testosterone, insulin-like growth factor 1, triiodothyronine and leptin <ref type="bibr" target="#b13">[14]</ref>.</s><s xml:id="_buJv636">Furthermore, RT reduced intermuscular adipose tissue <ref type="bibr" target="#b14">[15]</ref> and increased mitochondrial protein synthesis, mitochondrial oxidative function and thus accelerated the oxidation of glucose <ref type="bibr" target="#b15">[16]</ref>.</s><s xml:id="_JZS5UTU">In addition, RT increased muscle volume, skeletal muscle capillarization, the blood supply of muscle and thus increased glucose consumption <ref type="bibr" target="#b16">[17,</ref><ref type="bibr" target="#b17">18]</ref>.</s><s xml:id="_bSjVXuW">Eventually, randomized controlled trials of RT either by itself or in combination with aerobic activity have shown RT can improve glycemic control among prediabetes <ref type="bibr" target="#b4">[5,</ref><ref type="bibr" target="#b18">19]</ref>.</s><s xml:id="_y8VFkFq">It has been well established that RT is a useful strategy for the treatment of vascular disease and maintenance of vascular function in patients with T2DM <ref type="bibr" target="#b19">[20]</ref>.</s><s xml:id="_FkEqTqZ">Our study demonstrated that 24-month moderate resistance training was effective in reducing the CVD risk in participants with prediabetes.</s></p><p xml:id="_FGXauXT"><s xml:id="_86R5YKK">In our study, we found that after 24-month training no significant difference was found between experimental groups and controls group for HDL.</s><s xml:id="_DtZkQYx">Although systematic reviews <ref type="bibr" target="#b20">[21,</ref><ref type="bibr" target="#b21">22]</ref> have shown aerobic exercise increases HDL in subclinical and clinical populations, the effects of regular exercise on HDL function are variable and dependent upon several factors, including exercise dose and participant characteristics.</s><s xml:id="_bVWqqfB">Whereas exercise interventions may be less effective at improving HDL in older, diseased individuals compared with younger, healthier individuals <ref type="bibr" target="#b22">[23]</ref>.</s><s xml:id="_4Bu6cfX">Participants in our study were elderly prediabetes patients with a mean age of 60.52 ± 5.73 years.</s><s xml:id="_7S7P2vy">There may be a plausible explanation for the current finding.</s></p><p xml:id="_SKVCwS6"><s xml:id="_ZkdnFbP">There are several strengths in this study including large sample size and long study duration.</s><s xml:id="_nm54PaB">Further, in this multi-center, randomized controlled trial, all interventions were supervised by trained study personnel.</s><s xml:id="_eFBt9wA">Furthermore, intention-to-treat principle was applied to the data analysis.</s><s xml:id="_QXaUPwz">Last but not the least, the type of physical activity chosen (dancing and elastic bands).</s><s xml:id="_3wraB8k">Such inexpensive activity type can to be easily applicable to the general population, even in an "at-home" basis, and potentially help with the long-term adherence to a physical activity program.</s></p><p xml:id="_5Jnn83N"><s xml:id="_HUZYgHd">Our study has limitations.</s><s xml:id="_3P6wC9j">On the one hand, with 24-month duration of study, instead of the incidence of CVD, we used the FRS and the Chinese 10-year ICVD risk assessment tool to measure the CVD risk.</s><s xml:id="_NpVxkc5">On the other hand, a high loss-to-follow-up, with only 69.7% of subjects completing the 24-month study.</s><s xml:id="_BTv5UMq">Future work should consider how to improve retention, examine the role of resistance exercises of varying intensity on overall CVD risk and so on.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5." xml:id="_DhVSKKq">Conclusions</head><p xml:id="_4ckTxQd"><s xml:id="_GdH7c8N">In conclusion, we confirmed that 24-month moderate aerobic training reduced the Chinese 10-year ICVD risk and FRS cardiovascular disease risk in patients with prediabetes.</s><s xml:id="_3huk9hp">Resistance training group had significant reduction of cardiovascular disease risk (10year ICVD risk assessment) in prediabetes patients.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_X5FSCHc">Informed consent</head><p xml:id="_3BWh5Jp"><s xml:id="_6qgk2uu">I confirm all patient/personal identifiers have been removed or disguised so the patient/person(s) described are not identifiable and cannot be identified through the details of the story.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><figDesc><div><p xml:id="_4yHMQzq"><s xml:id="_7mww4ut">) an aerobic training group (AT group, n = 83); (3) a resistance training group (RT group, n = 82).</s><s xml:id="_zgaPtjH">The study was approved by the ethics committee of the Affiliated Hospital of Integrated Traditional Chinese and Western Medicine.</s><s xml:id="_kCyrfQ2">Written informed consents were obtained from all participants.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Fig. 1 .</head><label>1</label><figDesc><div><p xml:id="_B2QV4jp"><s xml:id="_UbuCZ7k">Fig. 1.</s><s xml:id="_bZufZbH">Study flow diagram.</s></p></div></figDesc><graphic coords="2,310.90,55.94,243.12,201.60" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Fig. 2 .</head><label>2</label><figDesc><div><p xml:id="_WhPt9Ep"><s xml:id="_EJRst5j">Fig. 2.1 depicts the range of individual subjects' responses among three groups.</s><s xml:id="_2CUkf4c">At the end of 12-month training, 63.8%, 47.5%</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Fig. 3 .</head><label>3</label><figDesc><div><p xml:id="_aPxrDMK"><s xml:id="_zsu6Su2">Fig. 3. Framingham Risks (%) and ICVD Risks (%) in the three group before and after 12-and 24-month training.</s><s xml:id="_SDwJQnZ">*P &lt; 0.05, **P &lt; 0.01 between baseline and after 12-and 24-month training.</s></p></div></figDesc><graphic coords="6,310.90,56.01,243.12,300.53" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Fig. 4 .</head><label>4</label><figDesc><div><p xml:id="_FrYX2Y7"><s xml:id="_jmaatn8">Fig. 4. Evaluation of AT and RT groups on the prediabetes of cardiovascular risk of ICVD.</s><s xml:id="_Dg8nnrk">The X-axis represents time.</s><s xml:id="_YYMunUA">Y-axis represents cardiovascular risk of ICVD (%).</s></p></div></figDesc><graphic coords="7,41.40,55.45,243.12,191.09" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1</head><label>1</label><figDesc><div><p xml:id="_K87nPsh"><s xml:id="_EqVGneP">Baseline characteristics.</s></p></div></figDesc><table><row><cell>Variables</cell><cell>AT (n = 83)</cell><cell>RT (n = 82)</cell><cell>Control (n = 83)</cell><cell>P value</cell></row><row><cell>Sex (female/male)</cell><cell>59/24</cell><cell>52/30</cell><cell>50/33</cell><cell>0.322</cell></row><row><cell>Age (years)</cell><cell>60.93 ± 5.71</cell><cell>59.91 ± 5.92</cell><cell>60.73 ± 5.83</cell><cell>0.496</cell></row><row><cell>Smoking (No/Yes)</cell><cell>70/13</cell><cell>71/11</cell><cell>71/12</cell><cell>0.912</cell></row><row><cell>BMI (kg/m 2 )</cell><cell>24.69 ± 2.78</cell><cell>24.69 ± 2.78</cell><cell>25.04 ± 2.86</cell><cell>0.743</cell></row><row><cell>FBG (mmol/L)</cell><cell>5.87 (5.60, 6.30)</cell><cell>5.97 (5.60, 6.30)</cell><cell>5.83 (5.29, 6.20)</cell><cell>0.370</cell></row><row><cell>2hPG (mmol/L)</cell><cell>7.61 (6.80, 8.70)</cell><cell>7.72 (6.50, 8.650</cell><cell>8.06 (7.00, 8.07)</cell><cell>0.165</cell></row><row><cell>HbA1c (%)</cell><cell>5.98 (5.70, 6.30)</cell><cell>5.92 (5.70, 6.20)</cell><cell>5.95 (5.70, 6.30)</cell><cell>0.525</cell></row><row><cell>SBP (mmHg)</cell><cell>135.51 (123.00, 148.00)</cell><cell>131.65 (122.00, 138.25)</cell><cell>136.75 (123.00, 150.00)</cell><cell>0.059</cell></row><row><cell>DBP (mmHg)</cell><cell>80.57 (73.00, 89.00)</cell><cell>77.99 (70.00, 88.00)</cell><cell>81.47 (76.00, 88.00)</cell><cell>0.129</cell></row><row><cell>Insulin (U/mL)</cell><cell>10.96 ± 4.16</cell><cell>11.14 ± 4.26</cell><cell>11.10 ± 3.77</cell><cell>0.958</cell></row><row><cell>HOMA2-IR</cell><cell>1.47 ± 0.54</cell><cell>1.50 ± 0.56</cell><cell>1.48 ± 0.48</cell><cell>0.954</cell></row><row><cell>HOMA2-␤</cell><cell>86.90 (66.80, 109.80)</cell><cell>87.01 (70.08, 99.85)</cell><cell>93.62 (66.70, 105.70)</cell><cell>0.714</cell></row><row><cell>TC (mmol/L)</cell><cell>5.30 ± 0.99</cell><cell>5.20 ± 0.92</cell><cell>5.17 ± 0.97</cell><cell>0.656</cell></row><row><cell>TG (mmol/L)</cell><cell>1.86 (1.16, 2.43)</cell><cell>1.88 (1.08, 2.55)</cell><cell>1.89 (1.02, 2.44)</cell><cell>0.822</cell></row><row><cell>HDL-C (mmol/L)</cell><cell>1.54 (1.25, 1.72)</cell><cell>1.47 (1.27, 1.68)</cell><cell>1.44 (1.17, 1.60)</cell><cell>0.081</cell></row><row><cell>LDL-C (mmol/L)</cell><cell>3.21 (2.73, 3.75)</cell><cell>3.07 (2.62, 3.47)</cell><cell>2.95 (2.43, 3.36)</cell><cell>0.073</cell></row><row><cell>Framingham Scores a</cell><cell>1.07 (1.04, 1.14)</cell><cell>1.07 (1.04, 1.14)</cell><cell>1.11 (1.04, 1.14)</cell><cell>0.132</cell></row><row><cell>Framingham Risks (%) a</cell><cell>1.00 (0.90, 1.20)</cell><cell>1.00 (0.90, 1.20)</cell><cell>1.07 (0.90, 1.20)</cell><cell>0.545</cell></row><row><cell>ICVD Scores</cell><cell>7.97 (6.46, 9.66)</cell><cell>7.10 (5.79, 8.60)</cell><cell>8 (6.28, 9.26)</cell><cell>0.591</cell></row><row><cell>ICVD Risks (%)</cell><cell>5.40 (3.29, 9.10)</cell><cell>4.06 (2.73, 6.54)</cell><cell>5.40 (3.18, 7.93)</cell><cell>0.597</cell></row><row><cell>Statins use</cell><cell>10</cell><cell>11</cell><cell>5</cell><cell>0.256</cell></row></table><note xml:id="_8mJB6r5"><p>Note: data are shown as means ± SD or median (25%, 75%). AT: aerobic training; RT: resistance training; BMI: Body mass index; FBG: fasting blood glucose; 2hPG: venous plasma glucose concentration 2 h after intake of 75 g oral glucose; HbA1c: haemoglobinA1c; SBP: systolic blood pressure; DBP: diastolic blood pressure; HOMA-2IR, homeostasis model assessment of insulin resistance; HOMA-2␤, homeostasis model assessment of beta cell function; TC: total cholesterol; TG: triacyl glycerol; HDL-C: high density lipoprotein cholesterol; LDL-C: low density lipoprotein cholesterol; ICVD: ischemic cardiovascular disease. b Square root transformation performed.</p><p><s xml:id="_k4zkA3f">a Logarithmic transformation (log10) performed.</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2</head><label>2</label><figDesc><div><p xml:id="_9cUbAMf"><s xml:id="_U6qbYJX">Before and after training between-group comparison of changes on clinical variables.</s></p></div></figDesc><table><row><cell>Variables</cell><cell>Time</cell><cell>RT (n = 82)</cell><cell>AT (n = 83)</cell><cell>Control (n = 83)</cell><cell>Group-time</cell><cell cols="2">Group P value</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>interaction</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell cols="3">RT vs control AT vs control RT vs AT</cell></row><row><cell></cell><cell>Baseline</cell><cell>6.00 (5.62, 6.30)</cell><cell>5.80 (5.60, 6.29)</cell><cell>6.00 (5.30, 6.27)</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>FBG</cell><cell cols="2">12-month 5.60 (5.25, 5.91)</cell><cell>5.68 (5.48, 5.88)</cell><cell>6.11 (5.70, 6.60)</cell><cell>P &lt; 0.001**</cell><cell>-</cell><cell>P &lt; 0.001**</cell><cell>P &lt; 0.001**</cell><cell>0.189</cell></row><row><cell></cell><cell cols="2">24-month 5.70 (5.39, 6.22)</cell><cell>5.58 (5.30, 5.89)</cell><cell>6.40 (5.87, 6.80)</cell><cell></cell><cell></cell><cell>P &lt; 0.001**</cell><cell>P &lt; 0.001**</cell><cell>0.059</cell></row><row><cell></cell><cell>Baseline</cell><cell>7.60 (6.50, 8.59)</cell><cell>7.72 (6.93, 8.50)</cell><cell>8.23 (7.15, 8.89)</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>2hPG</cell><cell cols="2">12-month 7.45(6.60, 8.54)</cell><cell>7.00 (6.47, 8.10)</cell><cell>7.91 (7.30, 8.55)</cell><cell>0.053</cell><cell>-</cell><cell>0.049*</cell><cell>0.010*</cell><cell>0.536</cell></row><row><cell></cell><cell cols="2">24-month 7.25 (6.53, 8.69)</cell><cell>7.10 (6.42, 8.00)</cell><cell>8.10 (7.41, 9.11)</cell><cell></cell><cell></cell><cell>0.006*</cell><cell>0.020*</cell><cell>0.743</cell></row><row><cell></cell><cell>Baseline</cell><cell>5.90 (5.70, 6.10)</cell><cell>6.00 (5.70, 6.30)</cell><cell>5.90 (5.70, 6.30)</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>HbA1c (%)</cell><cell cols="2">12-month 5.85 (5.53, 6.08)</cell><cell>5.70 (5.50, 5.90)</cell><cell>6.00 (5.60, 6.30)</cell><cell>P &lt; 0.001**</cell><cell>-</cell><cell>0.007*</cell><cell>P &lt; 0.001**</cell><cell>0.039*</cell></row><row><cell></cell><cell cols="2">24-month 5.80 (5.43, 6.20)</cell><cell>5.70 (5.50, 6.00)</cell><cell>6.20 (5.70, 6.60)</cell><cell></cell><cell></cell><cell>0.003**</cell><cell>P &lt; 0.001**</cell><cell>0.464</cell></row><row><cell></cell><cell>Baseline</cell><cell>1.50 (1.37, 1.62)</cell><cell>1.46 (1.35, 1.58)</cell><cell>1.48 (1.37, 1.58)</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>HOMA2-IR</cell><cell cols="2">12-month 1.13 (1.00, 1.47)</cell><cell>1.22 (1.03, 1.54)</cell><cell>1.36 (1.17, 1.55)</cell><cell>0.045*</cell><cell>-</cell><cell>0.026*</cell><cell>0.005*</cell><cell>0.789</cell></row><row><cell></cell><cell cols="2">24-month 0.96 (0.82, 1.47)</cell><cell>1.20 (0.99, 1.43)</cell><cell>1.34. (1.09, 1.51)</cell><cell></cell><cell></cell><cell>0.019*</cell><cell>0.003*</cell><cell>0.506</cell></row><row><cell></cell><cell>Baseline</cell><cell>9.21 (8.89, 9.54)</cell><cell>9.32 (9.00, 9.64)</cell><cell>9.51 (9.11, 9.90)</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>HOMA2-␤ b</cell><cell cols="2">12-month 9.45 (8.17, 10.78)</cell><cell>9.58 (8.92, 10.50)</cell><cell>8.29 (7.10, 9.17)</cell><cell>P &lt; 0.001**</cell><cell>-</cell><cell>P &lt; 0.001**</cell><cell>P &lt; 0.001**</cell><cell>0.392</cell></row><row><cell></cell><cell cols="2">24-month 9.79 (7.76, 10.38)</cell><cell>9.64 (8.79, 10.99)</cell><cell>7.30 (6.14, 9.04)</cell><cell></cell><cell></cell><cell>P &lt; 0.001**</cell><cell>P &lt; 0.001**</cell><cell>0.269</cell></row><row><cell></cell><cell>Baseline</cell><cell cols="3">24.81 (24.11, 25.51) 24.70 (24.09, 25.32) 25.04 (24.42, 25.66)</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>BMI</cell><cell cols="5">12-month 24.09 (21.99, 25.88) 23.83 (21.95, 26.03) 25.14 (23.73, 26.50) 0.033*</cell><cell>-</cell><cell>0.065</cell><cell>0.100</cell><cell>0.621</cell></row><row><cell></cell><cell cols="4">24-month 23.87 (22.34, 26.29) 23.55 (21.80, 25.96) 25.41 (23.52, 26.83)</cell><cell></cell><cell></cell><cell>0.063</cell><cell>0.005**</cell><cell>0.432</cell></row><row><cell></cell><cell>Baseline</cell><cell>5.20 (4.99, 5.40)</cell><cell>5.30 (5.08, 5.52)</cell><cell>5.17 (4.96, 5.38)</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>TC</cell><cell cols="2">12-month 4.85 (4.35, 5.370</cell><cell>4.83 (4.30, 5.46)</cell><cell>5.12 (4.57, 5.76)</cell><cell>0.004**</cell><cell>-</cell><cell>0.025*</cell><cell>0.049*</cell><cell>0.809</cell></row><row><cell></cell><cell cols="2">24-month 4.95 (4.37, 5.81)</cell><cell>4.98 (4.43, 5.47)</cell><cell>5.27 (4.50, 6.13)</cell><cell></cell><cell></cell><cell>0.017*</cell><cell>P &lt; 0.001**</cell><cell>0.168</cell></row><row><cell></cell><cell>Baseline</cell><cell>0.21 (0.16, 0.26)</cell><cell>0.23 (0.18, 0.27)</cell><cell>0.21 (0.15, 0.26)</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>TG</cell><cell cols="2">12-month 0.24 (0.04, 0.34)</cell><cell>0.21 (0.06, 0.35)</cell><cell>0.29 (0.05, 0.39)</cell><cell>0.387</cell><cell>0.585</cell><cell>0.193</cell><cell>0.122</cell><cell>0.803</cell></row><row><cell></cell><cell cols="2">24-month 0.21 (0.02, 0.34)</cell><cell>0.22 (0.08, 0.31)</cell><cell>0.25 (0.00, 0.39)</cell><cell></cell><cell></cell><cell>0.125</cell><cell>0.089</cell><cell>0.951</cell></row><row><cell></cell><cell>Baseline</cell><cell>1.49 (1.26, 1.68)</cell><cell>1.53 (1.25, 1.72)</cell><cell>1.36 (1.16, 1.57)</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>HDL-C</cell><cell cols="2">12-month 1.47 (1.30, 1.83)</cell><cell>1.62 (1.39, 1.81)</cell><cell>1.43 (1.20, 1.67)</cell><cell>0.308</cell><cell>0.149</cell><cell>0.935</cell><cell>0.616</cell><cell>0.457</cell></row><row><cell></cell><cell cols="2">24-month 1.58 (1.33, 1.82)</cell><cell>1.60 (1.27, 1.78)</cell><cell>1.39 (1.20, 1.56)</cell><cell></cell><cell></cell><cell>0.117</cell><cell>0.413</cell><cell>0.442</cell></row><row><cell></cell><cell>Baseline</cell><cell>1.74 (1.70, 1.78)</cell><cell>1.78 (1.73, 1.820</cell><cell>1.70 (1.65, 1.75)</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>LDL-C b</cell><cell cols="2">12-month 1.68 (1.57, 1.81)</cell><cell>1.73 (1.64, 1.92)</cell><cell>1.75 (1.58, 1.97)</cell><cell>0.046*</cell><cell>-</cell><cell>0.002**</cell><cell>0.014*</cell><cell>0.541</cell></row><row><cell></cell><cell cols="2">24-month 1.75 (1.64, 1.89)</cell><cell>1.73 (1.61, 2.00)</cell><cell>1.79 (1.59, 1.94)</cell><cell></cell><cell></cell><cell>0.017*</cell><cell>0.034*</cell><cell>0.938</cell></row><row><cell></cell><cell>Baseline</cell><cell cols="3">11.46 (11.32, 11.59) 11.62 (11.46, 11.77) 11.67 (11.53, 11.82)</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>SBP b</cell><cell cols="5">12-month 11.18 (10.89, 11.62) 11.40 (11.04, 11.78) 11.83 (11.40, 12.36) P &lt; 0.001**</cell><cell>-</cell><cell>0.001**</cell><cell>P &lt; 0.001**</cell><cell>0.590</cell></row><row><cell></cell><cell cols="4">24-month 11.31 (10.95, 11.48) 11.40 (11.09, 11.83) 11.83 (11.44, 12.24)</cell><cell></cell><cell></cell><cell>0.030*</cell><cell>0.006**</cell><cell>0.605</cell></row><row><cell></cell><cell>Baseline</cell><cell>8.81 (8.66, 8.95)</cell><cell>8.96 (8.81, 9.10)</cell><cell>9.01 (8.89, 9.13)</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>DBP b</cell><cell cols="2">12-month 8.68 (8.41, 8.94)</cell><cell>8.77 (8.36, 9.16)</cell><cell>9.16 (8.94, 9.38)</cell><cell>P &lt; 0.001**</cell><cell>-</cell><cell>P &lt; 0.001**</cell><cell>P &lt; 0.001**</cell><cell>0.266</cell></row><row><cell></cell><cell cols="2">24-month 8.83 (8.60, 9.11)</cell><cell>8.71 (8.42, 9.27)</cell><cell>9.11 (8.77, 9.38)</cell><cell></cell><cell></cell><cell>0.004**</cell><cell>P &lt; 0.001**</cell><cell>0.046</cell></row></table><note xml:id="_bqMjG7t"><p>Note: for all variables, the results are means (95% CI). AT: aerobic training; RT: resistance training; FBG: fasting blood glucose; 2hPG: venous plasma glucose concentration 2 h after intake of 75 g oral glucose; HbA1c: haemoglobinA1c; HOMA-2IR, homeostasis model assessment of insulin resistance; HOMA-2␤, homeostasis model assessment of beta cell function; BMI: Body mass index; TC: total cholesterol; TG: triacyl glycerol; HDL-C: high density lipoprotein cholesterol; LDL-C: low density lipoprotein cholesterol; SBP: systolic blood pressure; DBP: diastolic blood pressure; CI: confidence interval. P represents the comparison of changes between the groups. *Statistically significant difference compared to control group (*P &lt; 0.05, **P &lt; 0.01). a Logarithmic transformation (log10) performed.</p><p><s xml:id="_DDcTsKq">b Square root transformation performed.</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 3</head><label>3</label><figDesc><div><p><s xml:id="_ydj3hgR">Before and after training between-group comparison of changes on cardiovascular risk.Subjects with pre-diabetes underwent 12-and 24-month training.</s><s xml:id="_BbmKYAZ">HbA1c in response to exercise were measured as the post-exercise minus pre-exercise ( ) values.</s><s xml:id="_xmH2hzC">The X-axis represents each individual subject's data point.</s><s xml:id="_BbmbhBH">Y-axis data above and below the origin indicate increases and decreases, respectively in each variable in response to aerobic training, resistance training and in controls who did not exercise.</s><s xml:id="_W5uM5E9">(2.2) 2% patients with decrease of HbA1c values ≥5.7% to &lt;5.7%.</s><s xml:id="_esXY8QX">The X-axis represents time.</s><s xml:id="_zzYw4Hp">Y-axis represents % of patients.</s></p></div></figDesc><table><row><cell>Variables</cell><cell>Time</cell><cell>RT (n = 82)</cell><cell>AT (n = 83)</cell><cell>Control (n = 83)</cell><cell>Group-time</cell><cell cols="2">Group P value</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>interaction</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>RT vs control AT vs control RT vs AT</cell></row><row><cell></cell><cell>Baseline</cell><cell cols="3">1.07 (1.04, 1.14) 1.07 (1.04, 1.14) 1.11 (1.04, 1.14)</cell><cell></cell><cell></cell></row><row><cell>Framingham Scores a</cell><cell cols="5">12-month 1.07 (1.00, 1.12) 1.07 (1.00, 1.14) 1.11 (1.04, 1.140 0.256</cell><cell>0.242</cell><cell>0.051</cell><cell>0.024*</cell><cell>0.739</cell></row><row><cell></cell><cell cols="4">24-month 1.04 (1.00, 1.11) 1.07 (1.00, 1.11) 1.11 (1.04, 1.14)</cell><cell></cell><cell></cell><cell>0.143</cell><cell>0.244</cell><cell>0.854</cell></row><row><cell></cell><cell>Baseline</cell><cell cols="3">1.00 (0.90, 1.20) 1.00 (0.90, 1.20) 1.07 (0.90, 1.20)</cell><cell></cell><cell></cell></row><row><cell>Framingham Risks (%) a</cell><cell cols="4">12-month 1.00 (0.77, 1.11) 1.00 (0.77, 1.20) 1.07 (0.90, 1.20)</cell><cell>0.041*</cell><cell>-</cell><cell>0.084</cell><cell>0.007**</cell><cell>0.394</cell></row><row><cell></cell><cell cols="4">24-month 0.90 (0.77, 1.07) 1.00 (0.77, 1.07) 1.07 (0.90, 1.20)</cell><cell></cell><cell></cell><cell>0.135</cell><cell>0.012*</cell><cell>0.310</cell></row><row><cell></cell><cell>Baseline</cell><cell cols="3">2.66 (2.40, 2.93) 2.82 (2.53, 3.10) 2.82 (2.50, 3.04)</cell><cell></cell><cell></cell></row><row><cell>ICVD Scores b</cell><cell cols="4">12-month 2.44 (2.00, 2.78) 2.59 (2.29, 2.93) 2.73 (2.45, 2.99)</cell><cell>0.006*</cell><cell>-</cell><cell>0.001*</cell><cell>0.041*</cell><cell>0.206</cell></row><row><cell></cell><cell cols="4">24-month 2.47 (2.11, 2.86) 2.65 (2.34, 2.93) 2.79 (2.52, 3.03)</cell><cell></cell><cell></cell><cell>0.017*</cell><cell>0.018*</cell><cell>0.888</cell></row><row><cell></cell><cell>Baseline</cell><cell cols="3">0.60 (0.43, 0.81) 0.73 (0.51, 0.95) 0.73 (0.49, 0.89)</cell><cell></cell><cell></cell></row><row><cell>ICVD Risks (%) a</cell><cell cols="4">12-month 0.46 (0.15, 0.69) 0.55 (0.35, 0.81) 0.67 (0.45, 0.85)</cell><cell>0.005*</cell><cell>-</cell><cell>0.002*</cell><cell>0.040*</cell><cell>0.241</cell></row><row><cell></cell><cell cols="4">24-month 0.47 (0.25, 0.76) 0.60 (0.39, 0.81) 0.71 (0.51, 0.88)</cell><cell></cell><cell></cell><cell>0.026*</cell><cell>0.024*</cell><cell>0.982</cell></row></table><note xml:id="_wxDcWnZ"><p>Note: for all variables, the results are means (95% CI). AT: aerobic training; RT: resistance training; ICVD: ischemic cardiovascular disease; CI: confidence interval. P represents the comparison of changes between the groups. *Statistically significant difference compared to control group (*P &lt; 0.05, **P &lt; 0.01).</p><p><s xml:id="_qjNyxem">a Logarithmic transformation (log10) performed.</s><s xml:id="_6xDmUUS">b Square root transformation performed.</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 4</head><label>4</label><figDesc><div><p xml:id="_kBq6ahf"><s xml:id="_h6uuG2c">COX regression analysis of cardiovascular risk of ICVD.</s><s xml:id="_K8a4QjW">After 12-month training, 42.2%, 34.1% and 26.5% of the participants with decrease of HbA1c values ≥5.7% to &lt;5.7% in the AT group, RT group and control group, respectively.</s><s xml:id="_PtUsaT9">After 24-month training, 38.6%, 35.4%, and 21.7% of the participants with decrease of HbA1c values ≥5.7% to &lt;5.7% in the AT group, RT group and the control group, respectively, indicating a better effect of AT on HbA1c on long term.</s></p></div></figDesc><table><row><cell>Variables</cell><cell>HR</cell><cell>95%CI</cell><cell>P values</cell></row><row><cell>Control</cell><cell>-</cell><cell>-</cell><cell>0.046*</cell></row><row><cell>RT</cell><cell>0.419</cell><cell>0.415-0.942</cell><cell>0.037*</cell></row><row><cell>AT</cell><cell>0.310</cell><cell>0.447-0.866</cell><cell>0.026*</cell></row><row><cell>Age</cell><cell>1.035</cell><cell>1.019-1.051</cell><cell>&lt;0.001**</cell></row><row><cell>Gender</cell><cell>1.254</cell><cell>1.052-1.495</cell><cell>0.012*</cell></row><row><cell>Smoking</cell><cell>1.324</cell><cell>0.844-1.668</cell><cell>0.542</cell></row><row><cell>Statins</cell><cell>1.094</cell><cell>0.808-1.481</cell><cell>0.560</cell></row><row><cell>BMI</cell><cell>1.062</cell><cell>1.029-1.095</cell><cell>&lt;0.001**</cell></row><row><cell>WHR</cell><cell>0.414</cell><cell>0.169-1.018</cell><cell>0.055</cell></row><row><cell cols="4">Note: for all variables, the results are means (95% CI). AT: aerobic training; RT:</cell></row><row><cell cols="4">resistance training; BMI; Body mass index; WHR: Waist-to-Hip Ratio; HR: haz-</cell></row><row><cell cols="4">ard ratio; CI: confidence interval. *Statistically significant difference compared to</cell></row><row><cell cols="2">control group (*P &lt; 0.05, **P &lt; 0.01).</cell><cell></cell><cell></cell></row><row><cell cols="4">and 37.3% of the participants showed reduction in HbA1c in the AT</cell></row><row><cell cols="4">group, RT group and control group, respectively. After 24-month</cell></row><row><cell cols="4">training, 51.8%, 45.1%, and 25.3% of the participants showed a</cell></row><row><cell cols="4">decrease in the AT group, RT group and the control group, respec-</cell></row><row><cell>tively.</cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="4">Fig. 2.2 depicts % patients with decrease of HbA1c values ≥5.7%</cell></row><row><cell>to &lt;5.7%.</cell><cell></cell><cell></cell><cell></cell></row></table></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div><head xml:id="_EYJRZVJ">Acknowledgments</head><p xml:id="_6STc4Tt"><s xml:id="_kShGqk6">Participants were enrolled through three centers (The <rs type="funder">Affiliated Hospital of Integrated Traditional Chinese and Western Medicine</rs>, <rs type="funder">Nanjing University of Chinese Medicine</rs>.</s><s xml:id="_bFBXaGz">Dan yang People's <rs type="institution">Hospital of Jiangsu Province</rs>, The First Affiliated <rs type="institution">Hospital of Guangxi Medical University</rs>) from January to December, 2014.</s><s xml:id="_v8uVeVq">The investigators in the Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, <rs type="institution">Nanjing University of Chinese Medicine</rs> were XC, JTF, XD W, LL and QQL.</s><s xml:id="_6X53xC2">The investigators in Dan yang People's <rs type="institution">Hospital of Jiangsu Province</rs> was YH.</s><s xml:id="_jMDV7hX">The investigators in the <rs type="institution">First Affiliated Hospital of Guangxi Medical University</rs> was XD.</s></p><p xml:id="_rV7HYn3"><s xml:id="_Y5FWeNz">We certify that all authors have participated sufficiently in the work to take public responsibility for the appropriateness of the study design and method, and the collection, analysis, interpretation of the data and the manuscript revision.</s><s xml:id="_gKqrs3f">QQL conceived and designed the study.</s><s xml:id="_ZY8j7df">XC, QQL contributed to drafting and revising the manuscript critically for important intellectual content.</s><s xml:id="_tHTf92y">LL and ZHF supervised data collection and management.</s><s xml:id="_cqsQcsN">XD, JTF, YH and XDW assisted with patient recruitment and training supervision.</s><s xml:id="_AHUDQWa">XC, <rs type="person">CY Hsue</rs> and SQZ developed the statistical analysis plan for outcomes.</s><s xml:id="_kpYw5RT">QQL and JDM oversaw the data quality and revised the manuscript as needed.</s><s xml:id="_9NGmjx2">All authors have read, approved the final version and agreed to be responsible for all aspects of this work.</s></p></div>
			</div>
			<div type="funding">
<div><head xml:id="_6HTNHJV">Funding</head><p xml:id="_SJmzXAS"><s xml:id="_Y8zZ2y3">The trail was supported by grants from <rs type="funder">Natural Science Foundation of China</rs> (<rs type="grantNumber">81370923</rs>) and the <rs type="funder">Research Project of State Administration of Traditional Chinese Medicine</rs> of the P.R.C. (<rs type="grantNumber">JDZX2015132</rs>).</s><s xml:id="_tdfYr9d">All investigators are independent from funders.</s></p></div>
			</div>
			<listOrg type="funding">
				<org type="funding" xml:id="_pMCevZk">
					<idno type="grant-number">81370923</idno>
				</org>
				<org type="funding" xml:id="_376A4fy">
					<idno type="grant-number">JDZX2015132</idno>
				</org>
			</listOrg>

			<div type="availability">
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_pP2Dh3M">Availability of data and materials</head><p xml:id="_qfgC7xP"><s xml:id="_HQyRRw8">The data of this study is stored in the server of our organization.</s><s xml:id="_xeKyC4P">Whoever wishes to have access to it, can contact the first author.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_M5P5Xy2">Conflicts of interest</head><p xml:id="_aTpZaGc"><s xml:id="_4UKDepN">The authors state that they have no conflict of interest.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main" xml:id="_vhrNnBv">Differential role of insulin resistance and ␤-cell function in the development of prediabetes and diabetes in middle-aged and elderly Chinese population</title>
		<author>
			<persName><forename type="first">X</forename><surname>Cai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Xia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Pan</surname></persName>
		</author>
		<idno type="DOI">10.1186/s13098-019-0418-x</idno>
		<ptr target="http://dx.doi.org/10.1186/s13098-019-0418-x" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_FwE7GWr">Diabetol. Metab. Syndr</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page">24</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">X. Cai, L. Xia, Y. Pan, et al., Differential role of insulin resistance and ␤-cell function in the development of prediabetes and diabetes in middle-aged and elderly Chinese population, Diabetol. Metab. Syndr. 11 (2019) 24, http://dx.doi. org/10.1186/s13098-019-0418-x.</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main" xml:id="_WZkUEtc">Glycated hemoglobin, prediabetes, and the links to cardiovascular disease: data from UK Biobank</title>
		<author>
			<persName><forename type="first">C</forename><surname>Welsh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Welsh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Celis-Morales</surname></persName>
		</author>
		<idno type="DOI">10.1186/s13098-019-0418-x</idno>
		<ptr target="http://dx.doi.org/10.2337/dc19-1683" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_rU6h8xD">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="440" to="445" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">C. Welsh, P. Welsh, C.A. Celis-Morales, et al., Glycated hemoglobin, prediabetes, and the links to cardiovascular disease: data from UK Biobank, Diabetes Care 43 (2) (2020) 440-445, http://dx.doi.org/10.2337/dc19-1683.</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main" xml:id="_W24U5Cy">Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and metaanalysis</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Cai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Mai</surname></persName>
		</author>
		<idno type="DOI">10.2337/dc19-1683</idno>
		<ptr target="http://dx.doi.org/10.1136/bmj.i5953" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_rhqRSWZ">BMJ</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page">355</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Y. Huang, X. Cai, W. Mai, et al., Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta- analysis, BMJ 23 (11) (2016) 355, http://dx.doi.org/10.1136/bmj.i5953.</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main" xml:id="_bMdwK4U">Comparing the effects of six-month aerobic exercise and resistance training on metabolic control and beta cell function in Chinese patients with prediabetes: a multicenter randomized controlled trial</title>
		<author>
			<persName><forename type="first">X</forename><surname>Yuan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Dai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Liu</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmj.i5953</idno>
		<ptr target="http://dx.doi.org/10.1111/1753-0407.12955" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_bjmyZs2">J. Diabetes</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="25" to="37" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">X. Yuan, X. Dai, L. Liu, et al., Comparing the effects of six-month aerobic exercise and resistance training on metabolic control and beta cell function in Chi- nese patients with prediabetes: a multicenter randomized controlled trial, J. Diabetes 12 (1) (2019) 25-37, http://dx.doi.org/10.1111/1753-0407.12955.</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main" xml:id="_2WazTDH">Effect of 12-month resistance training on changes in abdominal adipose tissue and metabolic variables in patients with prediabetes: a randomized controlled trial</title>
		<author>
			<persName><forename type="first">Juan</forename><surname>Yan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Xia</forename><surname>Dai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jitao</forename><surname>Feng</surname></persName>
		</author>
		<idno type="DOI">10.1111/1753-0407.12955</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_63H2axT">J. Diabetes Res</title>
		<imprint>
			<biblScope unit="page">8469739</biblScope>
			<date type="published" when="2019">2019. 2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Juan Yan, Xia Dai, Jitao Feng, et al., Effect of 12-month resistance training on changes in abdominal adipose tissue and metabolic variables in patients with prediabetes: a randomized controlled trial, J. Diabetes Res. 2019 (2019), 8469739.</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main" xml:id="_Gkqr8uF">Strength training and the risk of type 2 diabetes and cardiovascular disease</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Shiroma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">R</forename><surname>Cook</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Manson</surname></persName>
		</author>
		<idno type="DOI">10.1249/mss.0000000000001063</idno>
		<ptr target="http://dx.doi.org/10.1249/MSS.0000000000001063" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_DrnnwKg">Med. Sci. Sports Exerc</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="40" to="46" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">E.J. Shiroma, N.R. Cook, J.E. Manson, et al., Strength training and the risk of type 2 diabetes and cardiovascular disease, Med. Sci. Sports Exerc. 49 (1) (2017) 40-46, http://dx.doi.org/10.1249/MSS.0000000000001063.</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main" xml:id="_zjzaQ4h">Exercise type and intensity in relation to coronary heart disease in men</title>
		<author>
			<persName><forename type="first">F</forename><surname>Tanasescu Mihaela</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">Rimm</forename><surname>Michael</surname></persName>
		</author>
		<author>
			<persName><surname>Eric</surname></persName>
		</author>
		<idno type="DOI">10.1249/MSS.0000000000001063</idno>
		<ptr target="http://dx.doi.org/10.1001/jama.288.16.1994" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_vPDE2PH">JAMA</title>
		<imprint>
			<biblScope unit="volume">288</biblScope>
			<biblScope unit="issue">16</biblScope>
			<biblScope unit="page" from="1994" to="2000" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Tanasescu Mihaela, F. Leitzmann Michael, B. Rimm Eric, et al., Exercise type and intensity in relation to coronary heart disease in men, JAMA 288 (16) (2002) 1994-2000, http://dx.doi.org/10.1001/jama.288.16.1994.</note>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main" xml:id="_PWwufGz">American Diabetes Association, American Diabetes Association&apos;s standards of medical care in diabetes-2020</title>
		<idno type="DOI">10.1001/jama.288.16.1994</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_VPTCvmS">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="1" to="S212" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note>Suppl. 1</note>
	<note type="raw_reference">American Diabetes Association, American Diabetes Association&apos;s standards of medical care in diabetes-2020, Diabetes Care 43 (Suppl. 1) (2020) S1-S212.</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main" xml:id="_csnbPBQ">A multivariate analysis of the risk of coronary heart disease in Framingham</title>
		<author>
			<persName><forename type="first">J</forename><surname>Tmett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Cornfield</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">B</forename><surname>Kannel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_A4rbhxs">J. Chronic Dis</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="511" to="524" />
			<date type="published" when="1967">1967</date>
		</imprint>
	</monogr>
	<note type="raw_reference">J. Tmett, J. Cornfield, W.B. Kannel, A multivariate analysis of the risk of coronary heart disease in Framingham, J. Chronic Dis. 20 (7) (1967) 511-524.</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main" xml:id="_ZsURxcT">Task group on the study of the comprehensive risk assessment and intervention program for coronary heart disease and stroke in the national &quot;fifteen&quot; project. Assessment of risk of ischemic cardiovascular disease in Chinese</title>
		<idno type="DOI">10.1007/978-94-011-5022-4_14</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_3uVhHfW">Chin. J. Cardiol</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="893" to="901" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Task group on the study of the comprehensive risk assessment and interven- tion program for coronary heart disease and stroke in the national &quot;fifteen&quot; project. Assessment of risk of ischemic cardiovascular disease in Chinese, Chin. J. Cardiol. 31 (12) (2003) 893-901.</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main" xml:id="_bURQYeK">Correct homeostasis model assessment (HOMA) evaluation uses the computer program</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Levy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Matthews</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Hermans</surname></persName>
		</author>
		<idno type="DOI">10.2337/diacare.21.12.2191</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_UdNMX3u">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="2191" to="2192" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
	<note type="raw_reference">J.C. Levy, D.R. Matthews, M.P. Hermans, Correct homeostasis model assessment (HOMA) evaluation uses the computer program, Diabetes Care 21 (12) (1998) 2191-2192.</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main" xml:id="_YMSEERg">Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Haffner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Lehto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Rönnemaa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Pyorala</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Laakso</surname></persName>
		</author>
		<idno type="DOI">10.1056/nejm199807233390404</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_cyrkSu2">N. Engl. J. Med</title>
		<imprint>
			<biblScope unit="volume">339</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="229" to="234" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
	<note type="raw_reference">S.M. Haffner, S. Lehto, T. Rönnemaa, K. Pyorala, M. Laakso, Mortality from coro- nary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction, N. Engl. J. Med. 339 (4) (1998) 229-234.</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main" xml:id="_rbnWqkB">Cardiovascular risk assessment based on US cohort studies: findings from a National Heart, Lung, and Blood Institute Work</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Onmdy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Agostino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Mosea</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_dnNmEJY">Circulation</title>
		<imprint>
			<biblScope unit="volume">104</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="491" to="496" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
	<note type="raw_reference">S.M. Onmdy, R.B. D Agostino, L. Mosea, et al., Cardiovascular risk assessment based on US cohort studies: findings from a National Heart, Lung, and Blood Institute Work, Circulation 104 (2) (2001) 491-496.</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main" xml:id="_Emyyb8X">Effects of eight weeks of time-restricted feeding (16/8) on basal metabolism, maximal strength, body composition, inflammation, and cardiovascular risk factors in resistancetrained males</title>
		<author>
			<persName><forename type="first">Moro</forename><surname>Tatiana</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Tinsley</forename><surname>Grant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Bianco</forename><surname>Antonino</surname></persName>
		</author>
		<idno type="DOI">10.1186/s12967-016-1044-0</idno>
		<ptr target="http://dx.doi.org/10.1186/s12967-016-1044-0" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_4enrDWS">J. Transl. Med</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="290" to="300" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Moro Tatiana, Tinsley Grant, Bianco Antonino, et al., Effects of eight weeks of time-restricted feeding (16/8) on basal metabolism, maximal strength, body composition, inflammation, and cardiovascular risk factors in resistance- trained males, J. Transl. Med. 14 (1) (2016) 290-300, http://dx.doi.org/10.1186/ s12967-016-1044-0.</note>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main" xml:id="_tauyjXW">Effects of high-intensity interval training and isoinertial training on leg extensors muscle function, structure, and intermuscular adipose tissue in older adults</title>
		<author>
			<persName><forename type="first">P</forename><surname>Bruseghini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Capelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Calabria</surname></persName>
		</author>
		<idno type="DOI">10.1186/s12967-016-1044-0</idno>
		<ptr target="http://dx.doi.org/10.3389/fphys.2019.01260" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_sAJgWK3">Front. Physiol</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page">1260</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">P. Bruseghini, C. Capelli, E. Calabria, et al., Effects of high-intensity interval training and isoinertial training on leg extensors muscle function, structure, and intermuscular adipose tissue in older adults, Front. Physiol. 10 (2019) 1260, http://dx.doi.org/10.3389/fphys.2019.01260.</note>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main" xml:id="_DcfRFMa">Skeletal muscle mitochondrial protein synthesis and respiration increase with low-load blood flow restricted as well as high-load resistance training</title>
		<author>
			<persName><forename type="first">T</forename><surname>Groennebaek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">R</forename><surname>Jespersen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Jakobsgaard</surname></persName>
		</author>
		<idno type="DOI">10.3389/fphys.2019.01260</idno>
		<ptr target="http://dx.doi.org/10.3389/fphys.2018.01796" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_SvM4zwu">Front. Physiol</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">1796</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">T. Groennebaek, N.R. Jespersen, J.E. Jakobsgaard, et al., Skeletal muscle mito- chondrial protein synthesis and respiration increase with low-load blood flow restricted as well as high-load resistance training, Front. Physiol. 9 (2018) 1796, http://dx.doi.org/10.3389/fphys.2018.01796.</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main" xml:id="_Mvsxh9b">The influence of prolonged strength training upon muscle and fat in healthy and chronically diseased older adults</title>
		<author>
			<persName><forename type="first">Anne</forename><surname>Gylling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Eriksen</forename><surname>Theil</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Christian</forename><surname>Skou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Garde</forename><surname>Ellen</surname></persName>
		</author>
		<idno type="DOI">10.3389/fphys.2018.01796</idno>
		<ptr target="http://dx.doi.org/10.1016/j.exger.2020.110939" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_kUG57WK">Exp. Gerontol</title>
		<imprint>
			<biblScope unit="volume">136</biblScope>
			<biblScope unit="page">110939</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Gylling Anne Theil, Eriksen Christian Skou, Garde Ellen, et al., The influence of prolonged strength training upon muscle and fat in healthy and chronically diseased older adults, Exp. Gerontol. 136 (2020), 110939, http://dx.doi.org/10. 1016/j.exger.2020.110939.</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main" xml:id="_tQDqu9P">Resistance training preserves high-intensity interval training induced improvements in skeletal muscle capillarization of healthy old men: a randomized controlled trial</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Leuchtmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Mueller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Aguayo</surname></persName>
		</author>
		<idno type="DOI">10.1038/s41598-020-63490-x</idno>
		<ptr target="http://dx.doi.org/10.1038/s41598-020-63490-x" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_hnSA7WU">Sci. Rep</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">6578</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">A.B. Leuchtmann, S.M. Mueller, D. Aguayo, et al., Resistance training preserves high-intensity interval training induced improvements in skeletal muscle cap- illarization of healthy old men: a randomized controlled trial, Sci. Rep. 10 (1) (2020) 6578, http://dx.doi.org/10.1038/s41598-020-63490-x.</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main" xml:id="_XfxDBEq">Two years supervised resistance training prevented diabetes incidence in people with prediabetes: a randomized control trial</title>
		<author>
			<persName><forename type="first">X</forename><surname>Dai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Zhai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><forename type="middle">Y</forename><surname>Chen</surname></persName>
		</author>
		<idno type="DOI">10.1038/s41598-020-63490-x</idno>
		<ptr target="http://dx.doi.org/10.1002/dmrr.3143" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_bPBh7aY">Diabetes Metab. Res. Rev</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page">3143</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">X. Dai, L. Zhai, Q.Y. Chen, et al., Two years supervised resistance training pre- vented diabetes incidence in people with prediabetes: a randomized control trial, Diabetes Metab. Res. Rev. 35 (5) (2019) e3143, http://dx.doi.org/10.1002/ dmrr.3143.</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main" xml:id="_VrSKDfD">Effects of resistance and combined training on vascular function in type 2 diabetes: a systematic review of randomized controlled trials</title>
		<author>
			<persName><forename type="first">Dos</forename><surname>Santos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Araujo</forename><surname>João</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Nunes</forename><surname>Macedo Fabrício</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Sales</forename><surname>Barreto André</surname></persName>
		</author>
		<idno type="DOI">10.1002/dmrr.3143</idno>
		<ptr target="http://dx.doi.org/10.1900/RDS.2019.15.16" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_Tj79dBu">Rev. Diabet. Stud</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="16" to="25" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Dos Santos Araujo João E, Nunes Macedo Fabrício, Sales Barreto André, et al., Effects of resistance and combined training on vascular function in type 2 dia- betes: a systematic review of randomized controlled trials, Rev. Diabet. Stud. 15 (2) (2019) 16-25, http://dx.doi.org/10.1900/RDS.2019.15.16.</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main" xml:id="_pvSzHmW">Effects of endurance training on serum lipids</title>
		<author>
			<persName><forename type="first">K</forename><surname>Fikenzer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Fikenzer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Laufs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Werner</surname></persName>
		</author>
		<idno type="DOI">10.1900/RDS.2019.15.16</idno>
		<ptr target="http://dx.doi.org/10.1016/j.vph.2017.11.005" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_WV8gYVW">Vasc. Pharmacol</title>
		<imprint>
			<biblScope unit="volume">101</biblScope>
			<biblScope unit="page" from="9" to="20" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">K. Fikenzer, S. Fikenzer, U. Laufs, C. Werner, Effects of endurance training on serum lipids, Vasc. Pharmacol. 101 (2018) 9-20, http://dx.doi.org/10.1016/j. vph.2017.11.005.</note>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main" xml:id="_Aus6eY5">Differential effects of aerobic exercise, resistance training and combined exercise modalities on cholesterol and the lipid profile: review, synthesis and recommendations</title>
		<author>
			<persName><forename type="first">S</forename><surname>Mann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Beedie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Jimenez</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.vph.2017.11.005</idno>
		<ptr target="http://dx.doi.org/10.1007/s40279-013-0110-5" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_PXrsrRF">Sports Med</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="211" to="221" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">S. Mann, C. Beedie, A. Jimenez, Differential effects of aerobic exercise, resistance training and combined exercise modalities on cholesterol and the lipid profile: review, synthesis and recommendations, Sports Med. 44 (2) (2014) 211-221, http://dx.doi.org/10.1007/s40279-013-0110-5.</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main" xml:id="_eZV6hKu">Effects of exercise on HDL functionality</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Ruiz-Ramie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Barber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Sarzynski</surname></persName>
		</author>
		<idno type="DOI">10.1007/s40279-013-0110-5</idno>
		<ptr target="http://dx.doi.org/10.1097/MOL.0000000000000568" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_atY4AEs">Curr. Opin. Lipidol</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="16" to="23" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">J.J. Ruiz-Ramie, J.L. Barber, M.A. Sarzynski, Effects of exercise on HDL function- ality, Curr. Opin. Lipidol. 30 (1) (2019) 16-23, http://dx.doi.org/10.1097/MOL. 0000000000000568.</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
